Recent Skin Cancer News

Select Targets to View
TOPICS: ·skin cancer
RELEVANCE:

Topic » skin cancer · [Clear All]

Add to New Notebook:

Notes:

First-Line Treatment With Merck’s KEYTRUDA® (pembrolizumab) Doubled Five-Year Survival Rate (31.9%) Versus Chemotherapy (16.3%) in Certain Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 (TPS >50%)

September 22, 2020 ·    skin cancer   

OnKure signs collaboration deal with Pfizer on melanoma treatment

September 22, 2020 ·    skin cancer   

Label changes coming to hydrochlorothiazide to warn about non-melanoma risk

September 22, 2020 ·    skin cancer   

Handheld Melanoma Scanner Market Size to Witness Huge Growth by 2027 | By Top Leading Vendors – Siemens AG, Strata Skin Sciences, AstraZeneca, Agilent Technology, Baxter International Inc, Roche, Abbott Laboratory

September 22, 2020 ·    skin cancer   

Provectus Biopharmceuticals Highlights Stage IV M1d Patient Outcome from Combination Therapy Trial of PV-10® and KEYTRUDA® for Checkpoint-Refractory Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020

September 21, 2020 ·    skin cancer   

Provectus Biopharmaceuticals Highlights Stage IV M1c Patient Outcome from Combination Therapy Trial of PV-10® and KEYTRUDA® for Checkpoint-Naïve Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020

September 21, 2020 ·    skin cancer   

Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar(R) and Mekinist(R) in advanced melanoma

September 21, 2020 ·    skin cancer   

MedX Health Corp. Bolsters Global Footprint and Adds Renowned Skin Care Expert to Senior Leadership Team

September 21, 2020 ·    skin cancer   

Dermatoscopes Market Size foreseen to grow exponentially over Forecast 2020 – 2025

September 21, 2020 ·    skin cancer   

Rare cancer survivor paddling down North Saskatchewan River for melanoma research

September 21, 2020 ·    skin cancer